TMEDLIO

Serial Number 79382510
Registration 7445424
700

Registration Progress

Application Filed
Sep 20, 2023
Under Examination
Approved for Publication
Apr 30, 2024
Published for Opposition
Apr 30, 2024
Registered
Jul 16, 2024

Trademark Image

TMEDLIO

Basic Information

Serial Number
79382510
Registration Number
7445424
Filing Date
September 20, 2023
Registration Date
July 16, 2024
Published for Opposition
April 30, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 16, 2024
Registration
Registered
Classes
005

Rights Holder

IO Biotech ApS

99
Address
Ole Maaløes Vej 3
DK-2200 Copenhagen N
DK

Ownership History

IO Biotech ApS

Original Applicant
99
DK

IO Biotech ApS

Owner at Publication
99
DK

IO Biotech ApS

Original Registrant
99
DK

Legal Representation

Attorney
Bryce J. Maynard

USPTO Deadlines

Next Deadline
1829 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-07-16)
Due Date
July 16, 2030
Grace Period Ends
January 16, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

30 events
Date Code Type Description
Apr 19, 2025 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 31, 2025 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 31, 2025 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 17, 2025 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 29, 2024 FIMP P FINAL DISPOSITION PROCESSED
Dec 29, 2024 FICS P FINAL DISPOSITION NOTICE SENT TO IB
Oct 18, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 16, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER
Jul 16, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 16, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER
Apr 30, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 30, 2024 PUBO A PUBLISHED FOR OPPOSITION
Apr 10, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 26, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 5, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED
Feb 5, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 5, 2024 GNEA O EXAMINERS AMENDMENT E-MAILED
Feb 5, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN
Jan 25, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 24, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 24, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 23, 2024 RFNT P REFUSAL PROCESSED BY IB
Dec 30, 2023 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 30, 2023 RFRR P REFUSAL PROCESSED BY MPU
Dec 20, 2023 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 19, 2023 CNRT R NON-FINAL ACTION WRITTEN
Dec 18, 2023 DOCK D ASSIGNED TO EXAMINER
Nov 10, 2023 MAFR O APPLICATION FILING RECEIPT MAILED
Nov 6, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 2, 2023 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Detailed Classifications

Class 005
Pharmaceutical preparations for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; synthetic peptides for pharmaceutical use for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; vaccines

Classification

International Classes
005

USPTO Documents

Click to view cached USPTO documents for this trademark

Only administrators can request new documents from USPTO